This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Chronic kidney disease
  • /
  • New mineralocorticoid receptor antagonists: update...
Journal

New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure

Read time: 1 mins
Published:31st Jan 2020
Author: Capelli I, Gasperoni L, Ruggeri M, Donati G, Baraldi O, Sorrenti G et al.
Availability: Pay for access, or by subscription
Ref.:J Nephrol. 2020 Feb;33(1):37-48.
DOI:10.1007/s40620-019-00600-7
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure


Aldosterone is a mineralocorticoid hormone with a well-known effect on the renal tubule leading to water retention and potassium reabsorption. Other major effects of the hormone include the induction of proinflammatory activity that leads to progressive fibrotic damage of the target organs, heart and kidney. Blocking the aldosterone receptor therefore represents an important pharmacological strategy to avoid the clinical conditions deriving from heart failure (CHF) and chronic kidney disease (CKD). However, steroidal mineralocorticoid receptor antagonists (MRA) have a low safety profile, especially in CKD patients due to the high incidence of hyperkalemia. A new generation of nonsteroidal MRA has recently been developed to obtain a selective receptor block avoiding side-effects like hyperkalemia and thereby making the drugs suitable for administration to CKD patients. This review summarizes the results of published preclinical and clinical studies on the nonsteroidal MRA, apararenone esaxerenone and finerenone. The trials showed a better safety profile with maintained drug efficacy compared with steroidal MRA. For this reason, nonsteroidal MRA represent an interesting new therapeutic approach for the prevention of CHF and CKD progression. Some basic research findings also yielded interesting results in acute clinical settings such as myocardial infarction and acute kidney injury.


Read abstract on library site    Access full article